<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">38735020</PMID><DateRevised><Year>2024</Year><Month>05</Month><Day>15</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Print">2110-5820</ISSN><JournalIssue CitedMedium="Print"><Volume>14</Volume><Issue>1</Issue><PubDate><Year>2024</Year><Month>May</Month><Day>12</Day></PubDate></JournalIssue><Title>Annals of intensive care</Title><ISOAbbreviation>Ann Intensive Care</ISOAbbreviation></Journal><ArticleTitle>Pulmonary redox imbalance drives early fibroproliferative response in moderate/severe coronavirus disease-19 acute respiratory distress syndrome and impacts long-term lung abnormalities.</ArticleTitle><Pagination><StartPage>72</StartPage><MedlinePgn>72</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">72</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1186/s13613-024-01293-3</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">COVID-19-associated pulmonary fibrosis remains frequent. This study aimed to investigate pulmonary redox balance in COVID-19 ARDS patients and possible relationship with pulmonary fibrosis and long-term lung abnormalities.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">Baseline data, chest CT fibrosis scores, N-terminal peptide of alveolar collagen III (NT-PCP-III), transforming growth factor (TGF)-&#x3b2;1, superoxide dismutase (SOD), reduced glutathione (GSH), oxidized glutathione (GSSG) and malondialdehyde (MDA) in bronchoalveolar lavage fluid (BALF) were first collected and compared between SARS-CoV-2 RNA positive patients with moderate to severe ARDS (n&#x2009;=&#x2009;65, COVID-19 ARDS) and SARS-CoV-2 RNA negative non-ARDS patients requiring mechanical ventilation (n&#x2009;=&#x2009;63, non-ARDS). Then, correlations between fibroproliferative (NT-PCP-III and TGF-&#x3b2;1) and redox markers were analyzed within COVID-19 ARDS group, and comparisons between survivor and non-survivor subgroups were performed. Finally, follow-up of COVID-19 ARDS survivors was performed to analyze the relationship between pulmonary abnormalities, fibroproliferative and redox markers 3&#xa0;months after discharge.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">Compared with non-ARDS group, COVID-19 ARDS group had significantly elevated chest CT fibrosis scores (p&#x2009;&lt;&#x2009;0.001) and NT-PCP-III (p&#x2009;&lt;&#x2009;0.001), TGF-&#x3b2;1 (p&#x2009;&lt;&#x2009;0.001), GSSG (p&#x2009;&lt;&#x2009;0.001), and MDA (p&#x2009;&lt;&#x2009;0.001) concentrations on admission, while decreased SOD (p&#x2009;&lt;&#x2009;0.001) and GSH (p&#x2009;&lt;&#x2009;0.001) levels were observed in BALF. Both NT-PCP-III and TGF-&#x3b2;1 in BALF from COVID-19 ARDS group were directly correlated with GSSG (p&#x2009;&lt;&#x2009;0.001) and MDA (p&#x2009;&lt;&#x2009;0.001) and were inversely correlated with SOD (p&#x2009;&lt;&#x2009;0.001) and GSH (p&#x2009;&lt;&#x2009;0.001). Within COVID-19 ARDS group, non-survivors (n&#x2009;=&#x2009;28) showed significant pulmonary fibroproliferation (p&#x2009;&lt;&#x2009;0.001) with more severe redox imbalance (p&#x2009;&lt;&#x2009;0.001) than survivors (n&#x2009;=&#x2009;37). Furthermore, according to data from COVID-19 ARDS survivor follow-up (n&#x2009;=&#x2009;37), radiographic residual pulmonary fibrosis and lung function impairment improved 3&#xa0;months after discharge compared with discharge (p&#x2009;&lt;&#x2009;0.001) and were associated with early pulmonary fibroproliferation and redox imbalance (p&#x2009;&lt;&#x2009;0.01).</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">Pulmonary redox imbalance occurring early in COVID-19 ARDS patients drives fibroproliferative response and increases the risk of death. Long-term lung abnormalities post-COVID-19 are associated with early pulmonary fibroproliferation and redox imbalance.</AbstractText><CopyrightInformation>&#xa9; 2024. The Author(s).</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y" EqualContrib="Y"><LastName>Yang</LastName><ForeName>Chun</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>The First Affiliated Hospital of Anhui Medical University, #218 Jixi Road, Hefei, 230022, Anhui, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y" EqualContrib="Y"><LastName>Tan</LastName><ForeName>Yuanyuan</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>The First Affiliated Hospital of Anhui Medical University, #218 Jixi Road, Hefei, 230022, Anhui, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Li</LastName><ForeName>Zihao</ForeName><Initials>Z</Initials><AffiliationInfo><Affiliation>The First Affiliated Hospital of Anhui Medical University, #218 Jixi Road, Hefei, 230022, Anhui, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hu</LastName><ForeName>Lei</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>The First Affiliated Hospital of Anhui Medical University, #218 Jixi Road, Hefei, 230022, Anhui, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chen</LastName><ForeName>Yuanyuan</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>The First Affiliated Hospital of Anhui Medical University, #218 Jixi Road, Hefei, 230022, Anhui, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhu</LastName><ForeName>Shouliang</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>The First Affiliated Hospital of Anhui Medical University, #218 Jixi Road, Hefei, 230022, Anhui, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hu</LastName><ForeName>Jiawei</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>The First Affiliated Hospital of Anhui Medical University, #218 Jixi Road, Hefei, 230022, Anhui, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Huai</LastName><ForeName>Tingting</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>The First Affiliated Hospital of Anhui Medical University, #218 Jixi Road, Hefei, 230022, Anhui, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Li</LastName><ForeName>Mingqing</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>The First Affiliated Hospital of Anhui Medical University, #218 Jixi Road, Hefei, 230022, Anhui, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhang</LastName><ForeName>Guobin</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>The First Affiliated Hospital of Anhui Medical University, #218 Jixi Road, Hefei, 230022, Anhui, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rao</LastName><ForeName>Dewang</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Anhui Medical University, #81 Meishan Road, Hefei, 230032, Anhui, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Fei</LastName><ForeName>Guanghe</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>The First Affiliated Hospital of Anhui Medical University, #218 Jixi Road, Hefei, 230022, Anhui, China. guanghefei@126.com.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Shao</LastName><ForeName>Min</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>The First Affiliated Hospital of Anhui Medical University, #218 Jixi Road, Hefei, 230022, Anhui, China. minicu2021@163.com.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ding</LastName><ForeName>Zhenxing</ForeName><Initials>Z</Initials><AffiliationInfo><Affiliation>The First Affiliated Hospital of Anhui Medical University, #218 Jixi Road, Hefei, 230022, Anhui, China. dingzhenxing@ahmu.edu.cn.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>KJ2021A0306</GrantID><Agency>Anhui Provincial Department of Education</Agency><Country/></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>05</Month><Day>12</Day></ArticleDate></Article><MedlineJournalInfo><Country>Germany</Country><MedlineTA>Ann Intensive Care</MedlineTA><NlmUniqueID>101562873</NlmUniqueID><ISSNLinking>2110-5820</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Acute respiratory distress syndrome</Keyword><Keyword MajorTopicYN="N">COVID-19</Keyword><Keyword MajorTopicYN="N">Long COVID</Keyword><Keyword MajorTopicYN="N">Oxidative stress</Keyword><Keyword MajorTopicYN="N">Pulmonary fibrosis</Keyword></KeywordList><CoiStatement>The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2023</Year><Month>12</Month><Day>9</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>4</Month><Day>10</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>5</Month><Day>12</Day><Hour>12</Hour><Minute>51</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>5</Month><Day>12</Day><Hour>12</Hour><Minute>50</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>5</Month><Day>12</Day><Hour>11</Hour><Minute>4</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>5</Month><Day>12</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">38735020</ArticleId><ArticleId IdType="pmc">PMC11089033</ArticleId><ArticleId IdType="doi">10.1186/s13613-024-01293-3</ArticleId><ArticleId IdType="pii">10.1186/s13613-024-01293-3</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Nalbandian A, Desai AD, Wan EY. Post-COVID-19 condition. Annu Rev Med. 2023;74:55&#x2013;64. doi: 10.1146/annurev-med-043021-030635.</Citation><ArticleIdList><ArticleId IdType="doi">10.1146/annurev-med-043021-030635</ArticleId><ArticleId IdType="pubmed">35914765</ArticleId></ArticleIdList></Reference><Reference><Citation>Oronsky B, Larson C, Hammond TC, Oronsky A, Kesari S, Lybeck M, et al. A review of persistent post-COVID syndrome (PPCS) Clin Rev Allergy Immunol. 2023;64(1):66&#x2013;74. doi: 10.1007/s12016-021-08848-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12016-021-08848-3</ArticleId><ArticleId IdType="pmc">PMC7896544</ArticleId><ArticleId IdType="pubmed">33609255</ArticleId></ArticleIdList></Reference><Reference><Citation>Verity R, Okell LC, Dorigatti I, Winskill P, Whittaker C, Imai N, et al. Estimates of the severity of coronavirus disease 2019: a model-based analysis. Lancet Infect Dis. 2020;20(6):669&#x2013;677. doi: 10.1016/S1473-3099(20)30243-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1473-3099(20)30243-7</ArticleId><ArticleId IdType="pmc">PMC7158570</ArticleId><ArticleId IdType="pubmed">32240634</ArticleId></ArticleIdList></Reference><Reference><Citation>Supady A, Combes A, Barbaro RP, Camporota L, Diaz R, Fan E, et al. Respiratory indications for ECMO: focus on COVID-19. Intensive Care Med. 2022;48(10):1326&#x2013;1337. doi: 10.1007/s00134-022-06815-w.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00134-022-06815-w</ArticleId><ArticleId IdType="pmc">PMC9362963</ArticleId><ArticleId IdType="pubmed">35945343</ArticleId></ArticleIdList></Reference><Reference><Citation>Li Z, Niu S, Guo B, Gao T, Wang L, Wang Y, et al. Stem cell therapy for COVID-19, ARDS and pulmonary fibrosis. Cell Prolif. 2020;53(12):e12939. doi: 10.1111/cpr.12939.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/cpr.12939</ArticleId><ArticleId IdType="pmc">PMC7645923</ArticleId><ArticleId IdType="pubmed">33098357</ArticleId></ArticleIdList></Reference><Reference><Citation>Hamon A, Scemama U, Bourenne J, Daviet F, Coiffard B, Persico N, et al. Chest CT scan and alveolar procollagen iii to predict lung fibroproliferation in acute respiratory distress syndrome. Ann Intensive Care. 2019;9(1):42. doi: 10.1186/s13613-019-0516-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13613-019-0516-9</ArticleId><ArticleId IdType="pmc">PMC6437222</ArticleId><ArticleId IdType="pubmed">30919111</ArticleId></ArticleIdList></Reference><Reference><Citation>Burnham EL, Hyzy RC, Paine RR, Kelly AM, Quint LE, Lynch D, et al. Detection of fibroproliferation by chest high-resolution CT scan in resolving ARDS. Chest. 2014;146(5):1196&#x2013;1204. doi: 10.1378/chest.13-2708.</Citation><ArticleIdList><ArticleId IdType="doi">10.1378/chest.13-2708</ArticleId><ArticleId IdType="pmc">PMC4219337</ArticleId><ArticleId IdType="pubmed">24722949</ArticleId></ArticleIdList></Reference><Reference><Citation>Mcdonald LT. Healing after COVID-19: are survivors at risk for pulmonary fibrosis? Am J Physiol Lung Cell Mol Physiol. 2021;320(2):L257&#x2013;L265. doi: 10.1152/ajplung.00238.2020.</Citation><ArticleIdList><ArticleId IdType="doi">10.1152/ajplung.00238.2020</ArticleId><ArticleId IdType="pmc">PMC7900916</ArticleId><ArticleId IdType="pubmed">33355522</ArticleId></ArticleIdList></Reference><Reference><Citation>George PM, Wells AU, Jenkins RG. Pulmonary fibrosis and COVID-19: the potential role for antifibrotic therapy. Lancet Respir Med. 2020;8(8):807&#x2013;815. doi: 10.1016/S2213-2600(20)30225-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2213-2600(20)30225-3</ArticleId><ArticleId IdType="pmc">PMC7228727</ArticleId><ArticleId IdType="pubmed">32422178</ArticleId></ArticleIdList></Reference><Reference><Citation>Polak SB, Van Gool IC, Cohen D, von der Th&#xfc;sen JH, van Paassen J. A systematic review of pathological findings in COVID-19: a pathophysiological timeline and possible mechanisms of disease progression. Mod Pathol. 2020;33(11):2128&#x2013;2138. doi: 10.1038/s41379-020-0603-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41379-020-0603-3</ArticleId><ArticleId IdType="pmc">PMC7306927</ArticleId><ArticleId IdType="pubmed">32572155</ArticleId></ArticleIdList></Reference><Reference><Citation>Yao XH, Luo T, Shi Y, He ZC, Tang R, Zhang PP, et al. A cohort autopsy study defines COVID-19 systemic pathogenesis. Cell Res. 2021;31(8):836&#x2013;846. doi: 10.1038/s41422-021-00523-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41422-021-00523-8</ArticleId><ArticleId IdType="pmc">PMC8208380</ArticleId><ArticleId IdType="pubmed">34135479</ArticleId></ArticleIdList></Reference><Reference><Citation>Sonnweber T, Sahanic S, Pizzini A, Luger A, Schwabl C, Sonnweber B, et al. Cardiopulmonary recovery after COVID-19: an observational prospective multicentre trial. Eur Respir J. 2021;57(4):2003481. doi: 10.1183/13993003.03481-2020.</Citation><ArticleIdList><ArticleId IdType="doi">10.1183/13993003.03481-2020</ArticleId><ArticleId IdType="pmc">PMC7736754</ArticleId><ArticleId IdType="pubmed">33303539</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang C, Wang Y, Li X, Ren L, Zhao J, Hu Y, et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet. 2020;395(10223):497&#x2013;506. doi: 10.1016/S0140-6736(20)30183-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(20)30183-5</ArticleId><ArticleId IdType="pmc">PMC7159299</ArticleId><ArticleId IdType="pubmed">31986264</ArticleId></ArticleIdList></Reference><Reference><Citation>Vijayakumar B, Tonkin J, Devaraj A, Philip K, Orton CM, Desai SR, et al. CT lung abnormalities after COVID-19 at 3 months and 1 year after hospital discharge. Radiology. 2022;303(2):444&#x2013;454. doi: 10.1148/radiol.2021211746.</Citation><ArticleIdList><ArticleId IdType="doi">10.1148/radiol.2021211746</ArticleId><ArticleId IdType="pmc">PMC8515207</ArticleId><ArticleId IdType="pubmed">34609195</ArticleId></ArticleIdList></Reference><Reference><Citation>Qin W, Chen S, Zhang Y, Dong F, Zhang Z, Hu B, et al. Diffusion capacity abnormalities for carbon monoxide in patients with COVID-19 at 3-month follow-up. Eur Respir J. 2021;58(1):2003677. doi: 10.1183/13993003.03677-2020.</Citation><ArticleIdList><ArticleId IdType="doi">10.1183/13993003.03677-2020</ArticleId><ArticleId IdType="pmc">PMC7877322</ArticleId><ArticleId IdType="pubmed">33574077</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhao YM, Shang YM, Song WB, Li QQ, Xie H, Xu QF, et al. Follow-up study of the pulmonary function and related physiological characteristics of COVID-19 survivors three months after recovery. EClinicalMedicine. 2020;25:100463. doi: 10.1016/j.eclinm.2020.100463.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.eclinm.2020.100463</ArticleId><ArticleId IdType="pmc">PMC7361108</ArticleId><ArticleId IdType="pubmed">32838236</ArticleId></ArticleIdList></Reference><Reference><Citation>Gonz&#xe1;lez J, Ben&#xed;tez ID, Carmona P, Santisteve S, Monge A, Moncus&#xed;-Moix A, et al. Pulmonary function and radiologic features in survivors of critical COVID-19: a 3-month prospective cohort. Chest. 2021;160(1):187&#x2013;198. doi: 10.1016/j.chest.2021.02.062.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.chest.2021.02.062</ArticleId><ArticleId IdType="pmc">PMC7930807</ArticleId><ArticleId IdType="pubmed">33676998</ArticleId></ArticleIdList></Reference><Reference><Citation>Hellemons ME, Huijts S, Bek LM, Berentschot JC, Nakshbandi G, Schurink C, et al. Persistent health problems beyond pulmonary recovery up to 6 months after hospitalization for COVID-19: a longitudinal study of respiratory, physical, and psychological outcomes. Ann Am Thorac Soc. 2022;19(4):551&#x2013;561. doi: 10.1513/AnnalsATS.202103-340OC.</Citation><ArticleIdList><ArticleId IdType="doi">10.1513/AnnalsATS.202103-340OC</ArticleId><ArticleId IdType="pmc">PMC8996273</ArticleId><ArticleId IdType="pubmed">34582728</ArticleId></ArticleIdList></Reference><Reference><Citation>Latronico N, Peli E, Calza S, Rodella F, Novelli MP, Cella A, et al. Physical, cognitive and mental health outcomes in 1-year survivors of COVID-19-associated ARDS. Thorax. 2022;77(3):300&#x2013;303. doi: 10.1136/thoraxjnl-2021-218064.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/thoraxjnl-2021-218064</ArticleId><ArticleId IdType="pubmed">34588274</ArticleId></ArticleIdList></Reference><Reference><Citation>Wijsenbeek M, Suzuki A, Maher TM. Interstitial lung diseases. Lancet. 2022;400(10354):769&#x2013;786. doi: 10.1016/S0140-6736(22)01052-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(22)01052-2</ArticleId><ArticleId IdType="pubmed">35964592</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhao M, Wang L, Wang M, Zhou S, Lu Y, Cui H, et al. Targeting fibrosis, mechanisms and clinical trials. Signal Transduct Target Ther. 2022;7(1):206. doi: 10.1038/s41392-022-01070-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41392-022-01070-3</ArticleId><ArticleId IdType="pmc">PMC9247101</ArticleId><ArticleId IdType="pubmed">35773269</ArticleId></ArticleIdList></Reference><Reference><Citation>Bradshaw PC, Seeds WA, Miller AC, Mahajan VR, Curtis WM. COVID-19: proposing a ketone-based metabolic therapy as a treatment to blunt the cytokine storm. Oxid Med Cell Longev. 2020;2020:6401341. doi: 10.1155/2020/6401341.</Citation><ArticleIdList><ArticleId IdType="doi">10.1155/2020/6401341</ArticleId><ArticleId IdType="pmc">PMC7519203</ArticleId><ArticleId IdType="pubmed">33014275</ArticleId></ArticleIdList></Reference><Reference><Citation>Otoupalova E, Smith S, Cheng G, Thannickal VJ. Oxidative stress in pulmonary fibrosis. Compr Physiol. 2020;10(2):509&#x2013;547. doi: 10.1002/cphy.c190017.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/cphy.c190017</ArticleId><ArticleId IdType="pubmed">32163196</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang J, Zhang M, Zhang WH, Zhu QM, Huo XK, Sun CP, et al. Total flavonoids of Inula japonica alleviated the inflammatory response and oxidative stress in LPS-induced acute lung injury via inhibiting the sEH activity: insights from lipid metabolomics. Phytomedicine. 2022;107:154380. doi: 10.1016/j.phymed.2022.154380.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.phymed.2022.154380</ArticleId><ArticleId IdType="pubmed">36150346</ArticleId></ArticleIdList></Reference><Reference><Citation>Guo Y, Liu Y, Zhao S, Xu W, Li Y, Zhao P, et al. Oxidative stress-induced FABP5 S-glutathionylation protects against acute lung injury by suppressing inflammation in macrophages. Nat Commun. 2021;12(1):7094. doi: 10.1038/s41467-021-27428-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-021-27428-9</ArticleId><ArticleId IdType="pmc">PMC8651733</ArticleId><ArticleId IdType="pubmed">34876574</ArticleId></ArticleIdList></Reference><Reference><Citation>Ornatowski W, Lu Q, Yegambaram M, Garcia AE, Zemskov EA, Maltepe E, et al. Complex interplay between autophagy and oxidative stress in the development of pulmonary disease. Redox Biol. 2020;36:101679. doi: 10.1016/j.redox.2020.101679.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.redox.2020.101679</ArticleId><ArticleId IdType="pmc">PMC7451718</ArticleId><ArticleId IdType="pubmed">32818797</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang C, Zhu X, Hua Y, Zhao Q, Wang K, Zhen L, et al. YY1 mediates TGF-&#x3b2;1-induced EMT and pro-fibrogenesis in alveolar epithelial cells. Respir Res. 2019;20(1):249. doi: 10.1186/s12931-019-1223-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12931-019-1223-7</ArticleId><ArticleId IdType="pmc">PMC6839144</ArticleId><ArticleId IdType="pubmed">31703732</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu F, Lagares D, Choi KM, Stopfer L, Marinkovi&#x107; A, Vrbanac V, et al. Mechanosignaling through YAP and TAZ drives fibroblast activation and fibrosis. Am J Physiol Lung Cell Mol Physiol. 2015;308(4):L344&#x2013;L357. doi: 10.1152/ajplung.00300.2014.</Citation><ArticleIdList><ArticleId IdType="doi">10.1152/ajplung.00300.2014</ArticleId><ArticleId IdType="pmc">PMC4329470</ArticleId><ArticleId IdType="pubmed">25502501</ArticleId></ArticleIdList></Reference><Reference><Citation>Rangarajan S, Bone NB, Zmijewska AA, Jiang S, Park DW, Bernard K, et al. Metformin reverses established lung fibrosis in a bleomycin model. Nat Med. 2018;24(8):1121&#x2013;1127. doi: 10.1038/s41591-018-0087-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-018-0087-6</ArticleId><ArticleId IdType="pmc">PMC6081262</ArticleId><ArticleId IdType="pubmed">29967351</ArticleId></ArticleIdList></Reference><Reference><Citation>Peng LY, An L, Sun NY, Ma Y, Zhang XW, Liu WH, et al. Salvia miltiorrhiza restrains reactive oxygen species-associated pulmonary fibrosis via targeting Nrf2-Nox4 redox balance. Am J Chin Med. 2019;47(5):1113&#x2013;1131. doi: 10.1142/S0192415X19500575.</Citation><ArticleIdList><ArticleId IdType="doi">10.1142/S0192415X19500575</ArticleId><ArticleId IdType="pubmed">31352786</ArticleId></ArticleIdList></Reference><Reference><Citation>Yu QY, Tang XX. Irreversibility of pulmonary fibrosis. Aging Dis. 2022;13(1):73&#x2013;86. doi: 10.14336/AD.2021.0730.</Citation><ArticleIdList><ArticleId IdType="doi">10.14336/AD.2021.0730</ArticleId><ArticleId IdType="pmc">PMC8782547</ArticleId><ArticleId IdType="pubmed">35111363</ArticleId></ArticleIdList></Reference><Reference><Citation>Habermann AC, Gutierrez AJ, Bui LT, Yahn SL, Winters NI, Calvi CL, et al. Single-cell RNA sequencing reveals profibrotic roles of distinct epithelial and mesenchymal lineages in pulmonary fibrosis. Sci Adv. 2020;6(28):eaba1972. doi: 10.1126/sciadv.aba1972.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/sciadv.aba1972</ArticleId><ArticleId IdType="pmc">PMC7439444</ArticleId><ArticleId IdType="pubmed">32832598</ArticleId></ArticleIdList></Reference><Reference><Citation>Lan YJ, Cheng MH, Ji HM, Bi YQ, Han YY, Yang CY, et al. Melatonin ameliorates bleomycin-induced pulmonary fibrosis via activating NRF2 and inhibiting galectin-3 expression. Acta Pharmacol Sin. 2023;44(5):1029&#x2013;1037. doi: 10.1038/s41401-022-01018-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41401-022-01018-x</ArticleId><ArticleId IdType="pmc">PMC9638373</ArticleId><ArticleId IdType="pubmed">36333557</ArticleId></ArticleIdList></Reference><Reference><Citation>Blanco-Melo D, Nilsson-Payant BE, Liu WC, Uhl S, Hoagland D, M&#xf8;ller R, et al. Imbalanced host response to SARS-CoV-2 drives development of COVID-19. Cell. 2020;181(5):1036&#x2013;1045. doi: 10.1016/j.cell.2020.04.026.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2020.04.026</ArticleId><ArticleId IdType="pmc">PMC7227586</ArticleId><ArticleId IdType="pubmed">32416070</ArticleId></ArticleIdList></Reference><Reference><Citation>Miripour ZS, Sarrami-Forooshani R, Sanati H, Makarem J, Taheri MS, Shojaeian F, et al. Real-time diagnosis of reactive oxygen species (ROS) in fresh sputum by electrochemical tracing; correlation between COVID-19 and viral-induced ROS in lung/respiratory epithelium during this pandemic. Biosens Bioelectron. 2020;165:112435. doi: 10.1016/j.bios.2020.112435.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bios.2020.112435</ArticleId><ArticleId IdType="pmc">PMC7341050</ArticleId><ArticleId IdType="pubmed">32729548</ArticleId></ArticleIdList></Reference><Reference><Citation>Barnes BJ, Adrover JM, Baxter-Stoltzfus A, Borczuk A, Cools-Lartigue J, Crawford JM, et al. Targeting potential drivers of COVID-19: neutrophil extracellular traps. J Exp Med. 2020;217(6):e20200652. doi: 10.1084/jem.20200652.</Citation><ArticleIdList><ArticleId IdType="doi">10.1084/jem.20200652</ArticleId><ArticleId IdType="pmc">PMC7161085</ArticleId><ArticleId IdType="pubmed">32302401</ArticleId></ArticleIdList></Reference><Reference><Citation>Verdecchia P, Cavallini C, Spanevello A, Angeli F. The pivotal link between ACE2 deficiency and SARS-CoV-2 infection. Eur J Intern Med. 2020;76:14&#x2013;20. doi: 10.1016/j.ejim.2020.04.037.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ejim.2020.04.037</ArticleId><ArticleId IdType="pmc">PMC7167588</ArticleId><ArticleId IdType="pubmed">32336612</ArticleId></ArticleIdList></Reference><Reference><Citation>Saheb SN, Saheb SF, Mdkhana B, Hussain AH, Alsafar H, Alrais ZF, et al. Upregulation of oxidative stress gene markers during SARS-COV-2 viral infection. Free Radic Biol Med. 2021;172:688&#x2013;698. doi: 10.1016/j.freeradbiomed.2021.06.018.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.freeradbiomed.2021.06.018</ArticleId><ArticleId IdType="pmc">PMC8233550</ArticleId><ArticleId IdType="pubmed">34186206</ArticleId></ArticleIdList></Reference><Reference><Citation>Olagnier D, Farahani E, Thyrsted J, Blay-Cadanet J, Herengt A, Idorn M, et al. SARS-CoV2-mediated suppression of NRF2-signaling reveals potent antiviral and anti-inflammatory activity of 4-octyl-itaconate and dimethyl fumarate. Nat Commun. 2020;11(1):4938. doi: 10.1038/s41467-020-18764-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-020-18764-3</ArticleId><ArticleId IdType="pmc">PMC7532469</ArticleId><ArticleId IdType="pubmed">33009401</ArticleId></ArticleIdList></Reference><Reference><Citation>Wei Y, Qi M, Liu C, Li L. Astragalus polysaccharide attenuates bleomycin-induced pulmonary fibrosis by inhibiting TLR4/NF-&#x3ba;B signaling pathway and regulating gut microbiota. Eur J Pharmacol. 2023;944:175594. doi: 10.1016/j.ejphar.2023.175594.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ejphar.2023.175594</ArticleId><ArticleId IdType="pubmed">36804541</ArticleId></ArticleIdList></Reference><Reference><Citation>Rui Y, Han X, Jiang A, Hu J, Li M, Liu B, et al. Eucalyptol prevents bleomycin-induced pulmonary fibrosis and M2 macrophage polarization. Eur J Pharmacol. 2022;931:175184. doi: 10.1016/j.ejphar.2022.175184.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ejphar.2022.175184</ArticleId><ArticleId IdType="pubmed">35964659</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen L, Ma Q, Zhang G, Lei Y, Wang W, Zhang Y, et al. Protective effect and mechanism of loganin and morroniside on acute lung injury and pulmonary fibrosis. Phytomedicine. 2022;99:154030. doi: 10.1016/j.phymed.2022.154030.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.phymed.2022.154030</ArticleId><ArticleId IdType="pubmed">35279615</ArticleId></ArticleIdList></Reference><Reference><Citation>Ichikado K, Suga M, M&#xfc;ller NL, Taniguchi H, Kondoh Y, Akira M, et al. Acute interstitial pneumonia: comparison of high-resolution computed tomography findings between survivors and nonsurvivors. Am J Respir Crit Care Med. 2002;165(11):1551&#x2013;1556. doi: 10.1164/rccm.2106157.</Citation><ArticleIdList><ArticleId IdType="doi">10.1164/rccm.2106157</ArticleId><ArticleId IdType="pubmed">12045132</ArticleId></ArticleIdList></Reference><Reference><Citation>Ichikado K, Muranaka H, Gushima Y, Kotani T, Nader HM, Fujimoto K, et al. Fibroproliferative changes on high-resolution CT in the acute respiratory distress syndrome predict mortality and ventilator dependency: a prospective observational cohort study. BMJ Open. 2012;2(2):e000545. doi: 10.1136/bmjopen-2011-000545.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmjopen-2011-000545</ArticleId><ArticleId IdType="pmc">PMC3293132</ArticleId><ArticleId IdType="pubmed">22382117</ArticleId></ArticleIdList></Reference><Reference><Citation>Centers for Disease Control and Prevention. CDC SARS response timeline 2013. Available from: www.cdc.gov/about/history/SARS/timeline.htm.</Citation></Reference><Reference><Citation>Hachmann NP, Miller J, Collier AY, Ventura JD, Yu J, Rowe M, et al. Neutralization escape by SARS-CoV-2 omicron subvariants BA.2.12.1, BA.4, and BA.5. N Engl J Med. 2022;387(1):86&#x2013;88. doi: 10.1056/NEJMc2206576.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMc2206576</ArticleId><ArticleId IdType="pmc">PMC9258748</ArticleId><ArticleId IdType="pubmed">35731894</ArticleId></ArticleIdList></Reference><Reference><Citation>Ackermann M, Verleden SE, Kuehnel M, Haverich A, Welte T, Laenger F, et al. Pulmonary vascular endothelialitis, thrombosis, and angiogenesis in Covid-19. N Engl J Med. 2020;383(2):120&#x2013;128. doi: 10.1056/NEJMoa2015432.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMoa2015432</ArticleId><ArticleId IdType="pmc">PMC7412750</ArticleId><ArticleId IdType="pubmed">32437596</ArticleId></ArticleIdList></Reference><Reference><Citation>Helms J, Tacquard C, Severac F, Leonard-Lorant I, Ohana M, Delabranche X, et al. High risk of thrombosis in patients with severe SARS-CoV-2 infection: a multicenter prospective cohort study. Intensive Care Med. 2020;46(6):1089&#x2013;1098. doi: 10.1007/s00134-020-06062-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00134-020-06062-x</ArticleId><ArticleId IdType="pmc">PMC7197634</ArticleId><ArticleId IdType="pubmed">32367170</ArticleId></ArticleIdList></Reference><Reference><Citation>Lin Z, Long F, Yang Y, Chen X, Xu L, Yang M. Serum ferritin as an independent risk factor for severity in COVID-19 patients. J Infect. 2020;81(4):647&#x2013;679. doi: 10.1016/j.jinf.2020.06.053.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jinf.2020.06.053</ArticleId><ArticleId IdType="pmc">PMC7313486</ArticleId><ArticleId IdType="pubmed">32592705</ArticleId></ArticleIdList></Reference><Reference><Citation>Li X, Geng M, Peng Y, Meng L, Lu S. Molecular immune pathogenesis and diagnosis of COVID-19. J Pharm Anal. 2020;10(2):102&#x2013;108. doi: 10.1016/j.jpha.2020.03.001.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jpha.2020.03.001</ArticleId><ArticleId IdType="pmc">PMC7104082</ArticleId><ArticleId IdType="pubmed">32282863</ArticleId></ArticleIdList></Reference><Reference><Citation>Forel JM, Guervilly C, Hraiech S, Voillet F, Thomas G, Somma C, et al. Type III procollagen is a reliable marker of ARDS-associated lung fibroproliferation. Intensive Care Med. 2015;41(1):1&#x2013;11. doi: 10.1007/s00134-014-3524-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00134-014-3524-0</ArticleId><ArticleId IdType="pubmed">25354475</ArticleId></ArticleIdList></Reference><Reference><Citation>Gao S, Li X, Jiang Q, Liang Q, Zhang F, Li S, et al. PKM2 promotes pulmonary fibrosis by stabilizing TGF-&#x3b2;1 receptor I and enhancing TGF-&#x3b2;1 signaling. Sci Adv. 2022;8(38):eabo0987. doi: 10.1126/sciadv.abo0987.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/sciadv.abo0987</ArticleId><ArticleId IdType="pmc">PMC9491720</ArticleId><ArticleId IdType="pubmed">36129984</ArticleId></ArticleIdList></Reference><Reference><Citation>Xu SW, Ilyas I, Weng JP. Endothelial dysfunction in COVID-19: an overview of evidence, biomarkers, mechanisms and potential therapies. Acta Pharmacol Sin. 2023;44(4):695&#x2013;709. doi: 10.1038/s41401-022-00998-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41401-022-00998-0</ArticleId><ArticleId IdType="pmc">PMC9574180</ArticleId><ArticleId IdType="pubmed">36253560</ArticleId></ArticleIdList></Reference><Reference><Citation>Komaravelli N, Casola A. Respiratory viral infections and subversion of cellular antioxidant defenses. J Pharmacogenomics Pharmacoproteomics. 2014;5(4):1000141.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4288774</ArticleId><ArticleId IdType="pubmed">25584194</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang S, Yu Y, Sheng M, Chen X, Wu Q, Kou J, et al. Ruscogenin timing administration mitigates cerebral ischemia-reperfusion injury through regulating circadian genes and activating Nrf2 pathway. Phytomedicine. 2023;120:155028. doi: 10.1016/j.phymed.2023.155028.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.phymed.2023.155028</ArticleId><ArticleId IdType="pubmed">37659295</ArticleId></ArticleIdList></Reference><Reference><Citation>Meng Y, Xu X, Xie G, Zhang Y, Chen S, Qiu Y, et al. Alkyl organophosphate flame retardants (OPFRs) induce lung inflammation and aggravate OVA-simulated asthmatic response via the NF-&#x43a;B signaling pathway. Environ Int. 2022;163:107209. doi: 10.1016/j.envint.2022.107209.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.envint.2022.107209</ArticleId><ArticleId IdType="pubmed">35358787</ArticleId></ArticleIdList></Reference><Reference><Citation>Zeng HL, Chen D, Yan J, Yang Q, Han QQ, Li SS, et al. Proteomic characteristics of bronchoalveolar lavage fluid in critical COVID-19 patients. Febs J. 2021;288(17):5190&#x2013;5200. doi: 10.1111/febs.15609.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/febs.15609</ArticleId><ArticleId IdType="pubmed">33098359</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang H, Wang L, Yang M, Hu J, Zhang E, Peng L. Oridonin attenuates LPS-induced early pulmonary fibrosis by regulating impaired autophagy, oxidative stress, inflammation and EMT. Eur J Pharmacol. 2022;923:174931. doi: 10.1016/j.ejphar.2022.174931.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ejphar.2022.174931</ArticleId><ArticleId IdType="pubmed">35398392</ArticleId></ArticleIdList></Reference><Reference><Citation>Li S, Zhou X, Zeng R, Lin L, Zou X, Yan Y, et al. YAP1 silencing attenuated lung injury/fibrosis but worsened diaphragmatic function by regulating oxidative stress and inflammation response in mice. Free Radic Biol Med. 2022;193(Pt 2):485&#x2013;498. doi: 10.1016/j.freeradbiomed.2022.10.323.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.freeradbiomed.2022.10.323</ArticleId><ArticleId IdType="pubmed">36336232</ArticleId></ArticleIdList></Reference><Reference><Citation>Bellanti F, Kasperczyk S, Kasperczyk A, Dobrakowski M, Pacilli G, Vurchio G, et al. Alteration of circulating redox balance in coronavirus disease-19-induced acute respiratory distress syndrome. J Intensive Care. 2023;11(1):30. doi: 10.1186/s40560-023-00679-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s40560-023-00679-y</ArticleId><ArticleId IdType="pmc">PMC10320967</ArticleId><ArticleId IdType="pubmed">37408073</ArticleId></ArticleIdList></Reference><Reference><Citation>Mart&#xed;n-Fern&#xe1;ndez M, Aller R, Heredia-Rodr&#xed;guez M, G&#xf3;mez-S&#xe1;nchez E, Mart&#xed;nez-Paz P, Gonzalo-Benito H, et al. Lipid peroxidation as a hallmark of severity in COVID-19 patients. Redox Biol. 2021;48:102181. doi: 10.1016/j.redox.2021.102181.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.redox.2021.102181</ArticleId><ArticleId IdType="pmc">PMC8572041</ArticleId><ArticleId IdType="pubmed">34768063</ArticleId></ArticleIdList></Reference><Reference><Citation>Yong SJ, Liu S. Proposed subtypes of post-covid-19 syndrome (or long-COVID) and their respective potential therapies. Rev Med Virol. 2022;32(4):e2315. doi: 10.1002/rmv.2315.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/rmv.2315</ArticleId><ArticleId IdType="pubmed">34888989</ArticleId></ArticleIdList></Reference><Reference><Citation>Hatabu H, Kaye KM, Christiani DC. Viral infection, pulmonary fibrosis, and long COVID. Am J Respir Crit Care Med. 2023;207(6):647&#x2013;649. doi: 10.1164/rccm.202211-2121ED.</Citation><ArticleIdList><ArticleId IdType="doi">10.1164/rccm.202211-2121ED</ArticleId><ArticleId IdType="pmc">PMC10037483</ArticleId><ArticleId IdType="pubmed">36470237</ArticleId></ArticleIdList></Reference><Reference><Citation>Burnham EL, Janssen WJ, Riches DW, Moss M, Downey GP. The fibroproliferative response in acute respiratory distress syndrome: mechanisms and clinical significance. Eur Respir J. 2014;43(1):276&#x2013;285. doi: 10.1183/09031936.00196412.</Citation><ArticleIdList><ArticleId IdType="doi">10.1183/09031936.00196412</ArticleId><ArticleId IdType="pmc">PMC4015132</ArticleId><ArticleId IdType="pubmed">23520315</ArticleId></ArticleIdList></Reference><Reference><Citation>Al-Hakeim HK, Al-Rubaye HT, Almulla AF, Al-Hadrawi DS, Maes M. Chronic fatigue, depression and anxiety symptoms in long COVID are strongly predicted by neuroimmune and neuro-oxidative pathways which are caused by the inflammation during acute infection. J Clin Med. 2023;12(2):511. doi: 10.3390/jcm12020511.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/jcm12020511</ArticleId><ArticleId IdType="pmc">PMC9865328</ArticleId><ArticleId IdType="pubmed">36675440</ArticleId></ArticleIdList></Reference><Reference><Citation>Stufano A, Isgr&#xf2; C, Palese LL, Caretta P, De Maria L, Lovreglio P, et al. Oxidative damage and post-COVID syndrome: a cross-sectional study in a cohort of Italian workers. Int J Mol Sci. 2023;24(8):7445. doi: 10.3390/ijms24087445.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms24087445</ArticleId><ArticleId IdType="pmc">PMC10139201</ArticleId><ArticleId IdType="pubmed">37108606</ArticleId></ArticleIdList></Reference><Reference><Citation>Singh SJ, Baldwin MM, Daynes E, Evans RA, Greening NJ, Jenkins RG, et al. Respiratory sequelae of COVID-19: pulmonary and extrapulmonary origins, and approaches to clinical care and rehabilitation. Lancet Respir Med. 2023;11(8):709&#x2013;725. doi: 10.1016/S2213-2600(23)00159-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2213-2600(23)00159-5</ArticleId><ArticleId IdType="pmc">PMC10198676</ArticleId><ArticleId IdType="pubmed">37216955</ArticleId></ArticleIdList></Reference><Reference><Citation>Luo J, Li P, Dong M, Zhang Y, Lu S, Chen M, et al. SLC15A3 plays a crucial role in pulmonary fibrosis by regulating macrophage oxidative stress. Cell Death Differ. 2024.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC11043330</ArticleId><ArticleId IdType="pubmed">38374230</ArticleId></ArticleIdList></Reference><Reference><Citation>Alipanah-Lechner N, Hurst-Hopf J, Delucchi K, Swigart L, Willmore A, Lacombe B, et al. Novel subtypes of severe covid-19 respiratory failure based on biological heterogeneity: a secondary analysis of a randomized controlled trial. Crit Care. 2024;28(1):56. doi: 10.1186/s13054-024-04819-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13054-024-04819-0</ArticleId><ArticleId IdType="pmc">PMC10882728</ArticleId><ArticleId IdType="pubmed">38383504</ArticleId></ArticleIdList></Reference><Reference><Citation>Vollbracht C, Kraft K. Feasibility of vitamin C in the treatment of post viral fatigue with focus on long COVID, based on a systematic review of IV vitamin C on fatigue. Nutrients. 2021;13(4):1154. doi: 10.3390/nu13041154.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/nu13041154</ArticleId><ArticleId IdType="pmc">PMC8066596</ArticleId><ArticleId IdType="pubmed">33807280</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang CP, Chang CM, Yang CC, Pariante CM, Su KP. Long COVID and long chain fatty acids (LCFAs): psychoneuroimmunity implication of omega-3 LCFAs in delayed consequences of COVID-19. Brain Behav Immun. 2022;103:19&#x2013;27. doi: 10.1016/j.bbi.2022.04.001.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbi.2022.04.001</ArticleId><ArticleId IdType="pmc">PMC8977215</ArticleId><ArticleId IdType="pubmed">35390469</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>